Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Clinical Ophthalmology (Auckland, N.Z.)|December 10, 2009
First-year treatment costs among new initiators of topical prostaglandin analogsJordana K Schmier, David W Covert, Alan L RobinClinical Drug Investigation|November 10, 2012
Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucomaJordana K Schmier, David W Covert, Edmund C LauCost Effectiveness and Resource Allocation : C/E|April 16, 2009
Single food focus dietary guidance: lessons learned from an economic analysis of egg consumptionJordana K Schmier, Leila M Barraj, Nga L TranManaged Care (Langhorne, Pa.)|May 12, 2006
The cost-effectiveness of omega-3 supplements for prevention of secondary coronary eventsJordana K Schmier, Nancy J Rachman, Michael T HalpernContemporary Clinical Trials|May 25, 2005
Practical applications of usability theory to electronic data collection for clinical trialsJordana K Schmier, David W Kane, Michael T HalpernDrugs & Aging|September 15, 2005
Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease patients: appraising the evidenceJordana K Schmier, Michael T Halpern, Mechelle L JonesPharmacoeconomics|April 12, 2006
The burden of age-related macular degenerationJordana K Schmier, Mechelle L Jones, Michael T HalpernHealth Care Financing Review|February 13, 2007
Resource utilization and costs of age-related macular degenerationMichael T Halpern, Jordana K Schmier, David Covert, et al.Clinical Ophthalmology (Auckland, N.Z.)|June 25, 2014
Adjunctive therapy patterns in glaucoma patients using prostaglandin analogsJordana K Schmier, Carolyn K Hulme-Lowe, David W CovertQuality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 12, 2001
Patient preferences and utilities for 'off-time' outcomes in the treatment of Parkinson's diseaseC S Palmer, J K Schmier, E Snyder, et al.Pageof 8